Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis

A Bahji, GH Vazquez, CA Zarate Jr - Journal of affective disorders, 2021 - Elsevier
Background Ketamine appears to have a therapeutic role in certain mental disorders, most
notably depression. However, the comparative performance of different formulations of …

Management of treatment-resistant depression: challenges and strategies

D Voineskos, ZJ Daskalakis… - … disease and treatment, 2020 - Taylor & Francis
Abstract Treatment-resistant depression (TRD) is a subset of Major Depressive Disorder
which does not respond to traditional and first-line therapeutic options. There are several …

Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis

Y Alnefeesi, D Chen-Li, E Krane, MY Jawad… - Journal of psychiatric …, 2022 - Elsevier
Ketamine is a promising therapeutic option in treatment-resistant depression (TRD). The
acute efficacy of ketamine in TRD has been demonstrated in replicated randomised …

Psychedelics in psychiatry: neuroplastic, immunomodulatory, and neurotransmitter mechanisms

A Inserra, D De Gregorio, G Gobbi - Pharmacological Reviews, 2021 - ASPET
Mounting evidence suggests safety and efficacy of psychedelic compounds as potential
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …

Side-effects associated with ketamine use in depression: a systematic review

B Short, J Fong, V Galvez, W Shelker… - The Lancet Psychiatry, 2018 - thelancet.com
This is the first systematic review of the safety of ketamine in the treatment of depression
after single and repeated doses. We searched MEDLINE, PubMed, PsycINFO, and …

Comorbid anxiety and depression: clinical and conceptual consideration and transdiagnostic treatment

KW Choi, YK Kim, HJ Jeon - Anxiety disorders: Rethinking and …, 2020 - Springer
Although anxiety and depression have been considered as two distinct entities according to
the diagnostic criteria, anxious depression (comorbid anxiety and depression) is relatively a …

[HTML][HTML] Ketamine treatment for depression: a review

M Yavi, H Lee, ID Henter, LT Park, CA Zarate Jr - Discover mental health, 2022 - Springer
This manuscript reviews the clinical evidence regarding single-dose intravenous (IV)
administration of the novel glutamatergic modulator racemic (R, S)-ketamine (hereafter …

[HTML][HTML] Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders

SB Sartori, N Singewald - Pharmacology & therapeutics, 2019 - Elsevier
Current medication for anxiety disorders is suboptimal in terms of efficiency and tolerability,
highlighting the need for improved drug treatments. In this review an overview of drugs …

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety

ED Ballard, DF Ionescu, JLV Voort, MJ Niciu… - Journal of psychiatric …, 2014 - Elsevier
Objective Suicide is a psychiatric emergency. Currently, there are no approved
pharmacologic treatments for suicidal ideation. Ketamine is an N-methyl-D-aspartate …

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: a randomized, double blind, placebo controlled trial

DF Ionescu, KH Bentley, M Eikermann, N Taylor… - Journal of affective …, 2019 - Elsevier
Background Several studies indicate that ketamine has rapid antidepressant effects in
patients with treatment-resistant depression (TRD). The extent to which repeated doses of …